微波诱导热疗保肢治疗胫骨远端骨肉瘤是否优于截肢
回顾性比较2000至2015年79例无转移胫骨远端骨肉瘤患者,52例接受微波诱导热疗保肢、27例截肢。两组6年生存率、局部复发和并发症比例无显著差异,但热疗组MSTS功能评分更高(85%±6% vs 66%±5%,p=0.008)。作者认为需更大样本、更长随访及与传统保肢方法比较的研究重复验证。
要点
- 微波诱导热疗保肢与截肢的6年生存率无显著差异(80% vs 70%,p=0.301)。
- 局部复发热疗组6例、截肢组0例,差异未达统计学显著(p=0.066)。
- 热疗组MSTS功能评分高于截肢组(85%±6% vs 66%±5%,p=0.008)。
核心结论
- 微波诱导热疗与截肢在早期生存、局部复发或严重并发症方面无差异,热疗组功能评分更优。
- 作者认为这些发现需在更大样本、更长平均随访时长及与传统保肢方法比较的研究中重复验证。
研究设计与样本
- 回顾性研究,纳入2000至2015年79例无转移的胫骨远端骨肉瘤患者,52例接受微波诱导热疗,27例接受截肢。
- 热疗组平均随访79个月(范围12-158个月),截肢组平均随访95个月(范围15-142个月),所有患者至少随访12个月。
- 另13例因患者偏好接受传统保肢切除重建而未纳入本研究;若胫后动脉和足背动脉均无法保留则行截肢且不纳入任何组。
- 热疗适用条件为肿瘤边缘至关节面至少20 mm、对新辅助化疗临床和影像反应良好、无病理性骨折。
- 两组在性别、年龄、肿瘤分级、分期或大小方面无差异;采用Kaplan-Meier分析生存,并发症按Dindo分类分级。
主要发现
- 热疗组6年Kaplan-Meier生存率为80%(95%CI,63%-90%),截肢组为70%(95%CI,37%-90%),差异无统计学显著(p=0.301)。
- 局部复发热疗组6例 vs 截肢组0例,差异未达统计学显著(p=0.066)。
- MSTS功能评分热疗组85%±6% vs 截肢组66%±5%,热疗组更高(p=0.008)。
- 并发症比例热疗组6/52(12%) vs 截肢组3/27(11%),差异无统计学显著(p=0.954)。
局限性
- 作者指出这些发现需在更大样本、更长平均随访时长及与传统保肢方法比较的研究中重复验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Amputation has been the standard surgical treatment for distal tibia osteosarcoma owing to its unique anatomic features. Preliminary research suggested that microwave-induced hyperthermia may have a role in treating osteosarcoma in some locations of the body (such as the pelvis), but to our knowledge, no comparative study has evaluated its efficacy in a difficult-to-treat location like the distal tibia. QUESTIONS: Does microwave-induced hyperthermia result in (1) improved survival, (2) decreased local recurrence, (3) improved Musculoskeletal Tumor Society (MSTS) scores, or (4) fewer complications than amputation in patients with a distal tibial osteosarcoma? METHODS: Between 2000 and 2015, we treated 79 patients for a distal tibia osteosarcoma without metastases. Of those, 52 were treated with microwave-induced hyperthermia, and 27 with amputation. Patients were considered eligible for microwave-induced hyperthermia if they had an at least 20-mm available distance from the tumor edge to the articular surface, good clinical and imaging response to neoadjuvant chemotherapy, and no pathologic fracture. Patients not meeting these indications were treated with amputation. In addition, if neither the posterior tibial artery nor the dorsalis pedis artery was salvageable, the patients were treated with amputation and were not included in any group in this study. A total of 13 other patients were treated with conventional limb-salvage resections and reconstructions (at the request of the patient, based on patient preference) and were not included in this study. All 79 patients in this retrospective study were available for followup at a minimum of 12 months (mean followup in the hyperthermia group, 79 months, range 12-158 months; mean followup in the amputation group, 95 months, range, 15-142 months). With the numbers available, the groups were no different in terms of sex, age, tumor grade, tumor stage, or tumor size. All statistical tests were two-sided, and a probability less than 0.05 was considered statistically significant. Survival to death was evaluated using Kaplan-Meier analysis. Complications were recorded from the patients' files and graded using the classification of surgical complications described by Dindo et al. RESULTS: In the limb-salvage group, Kaplan Meier survival at 6 years was 80% (95% CI, 63%-90%), and this was not different with the numbers available from survivorship in the amputation group at 6 years (70%; 95% CI, 37%-90%; p = 0.301).With the numbers available, we found no difference in local recurrence (six versus 0; p = 0.066). However mean ± SD MSTS functional scores were higher in patients who had microwave-induced hyperthermia compared with those who had amputations (85% ± 6% versus 66% ± 5%; p = 0.008).With the numbers available, we found no difference in the proportion of patients experiencing complications between the two groups (six of 52 [12%] versus three of 27 [11%]; p = 0.954). CONCLUSIONS: We were encouraged to find no early differences in survival, local recurrence, or serious complications between microwave-induced hyperthermia and amputation, and a functional advantage in favor of microwave-induced hyperthermia. However, these findings should be replicated in larger studies with longer mean duration of followup, and in studies that compare microwave-induced hyperthermia with conventional limb-sparing approaches. LEVEL OF EVIDENCE: Level III, therapeutic study.
引用
- Han K, Dang P, Bian N, et al. Is Limb Salvage With Microwave-induced Hyperthermia Better Than Amputation for Osteosarcoma of the Distal Tibia? Clin Orthop Relat Res. 2017. PMID: 28194714. doi:10.1007/s11999-017-5273-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。